Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06519890 · ClinicalTrials.gov registry record
Stanford ICU Delirium PIPRA Study
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 199
- Enrollment target
NCT06519890: Completed study, sponsored by Stanford University.
NCT06519890 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 199 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06519890 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 199 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the accuracy of the Pre-Interventional Preventive Risk Assessment (PIPRA) tool in predicting clinical cases of Intensive Care Units (ICU)-delirium, in a population at high risk of developing this syndrome (i.e., admitted patients to Cardiothoracic Intensive Care Units). The population to be studied has already been enrolled in a parallel study intended to determine the accuracy of an electroencephalogram (EEG)-based diagnosis for delirium.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2024-04-30 |
| Est. Completion | 2024-07-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06519890
The ClinicalTrials.gov registry entry for NCT06519890 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT06519890 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06519890 about?
NCT06519890 is a clinical study titled "Stanford ICU Delirium PIPRA Study". The purpose of this study is to determine the accuracy of the Pre-Interventional Preventive Risk Assessment (PIPRA) tool in predicting clinical cases of Intensive Care Units (ICU)-delirium, in a population at high risk of developing this syndrome (i.e., admitted patients to Cardiothoracic Intensive ...
What is the current status of trial NCT06519890?
This trial is currently completed. The enrollment target is 199 participants. The study started on 2024-04-30. Estimated completion is 2024-07-27.
Who is sponsoring clinical trial NCT06519890?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.